Literature DB >> 15286404

Analysis of human chorionic gonadotropin-monoclonal antibody interaction in BIAcore.

Banerjee Ashish1, Gundlupet Satyanarayana Murthy.   

Abstract

Kinetic studies of macromolecular ligant-ligate interaction have generated ample interest since the advent of plasmon resonance based instruments like BIAcore. Most of the studies reported in literature assume a simple 1:1 Langmuir binding and complete reversibility of the system. However we observed that in a high affinity antigen-antibody system [human chlorionic gonadotropin-monoclonal antibody (hCG-mAb)] dissociation in insignificant and the sensogram data cannot be used to measure the equilibrium and kinetic parameters. At low concentrations of mAb the complete sensogram could be fitted to a single exponential. Interestingly we found that at higher mAb concentrations, the binding data did not conform to a sample biomolecular model. Instead, the data fitted a two-step model, which may be because of surface heterogeneity of affinity sites. In this paper, we report on the global fit of the sensograms. We have developed a method by which a single two-minute sensogram can be used in high affinity systems to measure the association rate constant of the reaction and the functional capacity of the ligand (hCG) immobilized on the chip. We provide a rational explanation for the discrepancies generally observed in most of the BIAcore sensograms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286404     DOI: 10.1007/BF02702562

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  14 in total

1.  Surface plasmon resonance studies resolve the enigmatic endotoxin neutralizing activity of polymyxin B.

Authors:  C J Thomas; N Surolia; A Surolia
Journal:  J Biol Chem       Date:  1999-10-15       Impact factor: 5.157

Review 2.  Experimental design for analysis of complex kinetics using surface plasmon resonance.

Authors:  C A Lipschultz; Y Li; S Smith-Gill
Journal:  Methods       Date:  2000-03       Impact factor: 3.608

3.  Kinetic analysis of the binding of Ulex europeas agglutinin 1 (UEA 1) to H-antigenic fucolipid.

Authors:  C J Thomas; A Surolia
Journal:  Arch Biochem Biophys       Date:  2000-02-01       Impact factor: 4.013

Review 4.  Biospecific interaction analysis using biosensor technology.

Authors:  M Malmqvist
Journal:  Nature       Date:  1993-01-14       Impact factor: 49.962

5.  Thermodynamics and kinetics of the reaction of a single-chain antibody fragment (scFv) with the leucine zipper domain of transcription factor GCN4.

Authors:  S Weber-Bornhauser; J Eggenberger; I Jelesarov; A Bernard; C Berger; H R Bosshard
Journal:  Biochemistry       Date:  1998-09-15       Impact factor: 3.162

6.  Lysenin, a novel sphingomyelin-specific binding protein.

Authors:  A Yamaji; Y Sekizawa; K Emoto; H Sakuraba; K Inoue; H Kobayashi; M Umeda
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

7.  Immunochemical approach to the mapping of an assembled epitope of human chorionic gonadotropin: proximity of CTP-alpha to the receptor binding region of the beta-subunit.

Authors:  N Venkatesh; G S Murthy
Journal:  J Immunol Methods       Date:  1997-03-28       Impact factor: 2.303

8.  Measurement of kinetic binding constants of viral antibodies using a new biosensor technology.

Authors:  J L Pellequer; M H Van Regenmortel
Journal:  J Immunol Methods       Date:  1993-11-05       Impact factor: 2.303

9.  Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine.

Authors:  A J Muslin; J W Tanner; P M Allen; A S Shaw
Journal:  Cell       Date:  1996-03-22       Impact factor: 41.582

10.  Effects of solute multivalence on the evaluation of binding constants by biosensor technology: studies with concanavalin A and interleukin-6 as partitioning proteins.

Authors:  N L Kalinin; L D Ward; D J Winzor
Journal:  Anal Biochem       Date:  1995-07-01       Impact factor: 3.365

View more
  1 in total

1.  Small antibody fusion proteins with complementarity-determining regions and lidamycin for tumor targeting therapy.

Authors:  Gen-Shen Zhong; Min-Na Wu; Xiao-Fang Guo; Zhi-Shan Xu; Sheng-Hua Zhang; Yong-Su Zhen
Journal:  Oncol Lett       Date:  2013-01-18       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.